Respiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia | Zendy

Michael Klompas | Zendy; Peter B. Imrey | Zendy; Pei-Chun Yu | Zendy; Chanu Rhee | Zendy; Abhishek Deshpande | Zendy; Sarah Haessler | Zendy; Marya D. Zilberberg | Zendy; Michael B. Rothberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Respiratory viral testing and antibacterial treatment in patients hospitalized with community-acquired pneumonia

Author(s) -

Michael Klompas,

Peter B. Imrey,

Pei-Chun Yu,

Chanu Rhee,

Abhishek Deshpande,

Sarah Haessler,

Marya D. Zilberberg,

Michael B. Rothberg

Publication year - 2020

Publication title -

infection control and hospital epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.243

H-Index - 138

eISSN - 1559-6834

pISSN - 0899-823X

DOI - 10.1017/ice.2020.1312

Subject(s) - rhinovirus , medicine , pneumonia , viral pneumonia , community acquired pneumonia , bacterial pneumonia , respiratory system , virus , antimicrobial , immunology , covid-19 , microbiology and biotechnology , biology , infectious disease (medical specialty) , disease

Viruses are more common than bacteria in patients hospitalized with community-acquired pneumonia. Little is known, however, about the frequency of respiratory viral testing and its associations with antimicrobial utilization.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research